| (210) | Number of the EPO application | 18746942 |
| (220) | Filing date of the EPO application | 2018.07.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 08/2022, 2022.02.23 |
| (110) | EPO patent number | 3658115 |
| (21) | Number of the application | e 2020 0580 |
| (71) | Name(s) of applicant(s), code of the country | Adocia, FR; |
| (72) | Name(s) of inventor(s), code of the country | CHAN You-Ping, FR; |
| (73) | Name(s) of owner(s), code of the country | Adocia, FR; |
| (54) | Title of the invention | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AT LEAST HUMAN INSULIN A21G AND A PRANDIAL ACTION GLUCAGON SUPPRESSOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/26 (2006.01.01); A61K 38/28 (2006.01.01); A61K 45/06 (2006.01.01); A61K 47/02 (2006.01.01); A61K 9/08 (2006.01.01); A61K 31/198 (2006.01.01); C07K 14/62 (2006.01.01); A61P 3/10 (2006.01.01); A61P 5/48 (2006.01.01) |
| (19) | Country | FR |
| (41) | Date of publication of the application | 2020.06.30 |
| (30) | Priority | 1757172, 2017.07.27, FR; 1757184, 2017.07.28, FR; 1855250, 2018.06.14, FR |
| (86) | International application | PCT/EP2018/070510, 2018.07.27 |
| (87) | International publication | WO 2019/020820, 2019.01.31 |